Portfolios
Track your investments in one place, get AI insights, and more
Top movers in your lists
arrow_downward Symbols arrow_downward Symbols | arrow_downward Price | arrow_downward Change | arrow_downward % Change | Trend | arrow_downward Prev Close | arrow_downward Open | arrow_downward High | arrow_downward Low | arrow_downward Volume | arrow_downward Mkt Cap | |
|---|---|---|---|---|---|---|---|---|---|---|---|
SIXV Health care | SIXV +3.25% arrow_upward | 1,769.19 | +55.69 arrow_upward | +3.25% arrow_upward | — | 1,713.50 | 1,738.09 | 1,769.19 | 1,738.09 | — | — |
SIXB Materials | SIXB +2.01% arrow_upward | 1,120.59 | +22.04 arrow_upward | +2.01% arrow_upward | — | 1,098.55 | 1,102.59 | 1,121.88 | 1,102.59 | — | — |
SIXR Staples | SIXR +1.52% arrow_upward | 876.49 | +13.16 arrow_upward | +1.52% arrow_upward | — | 863.33 | 865.66 | 876.80 | 865.35 | — | — |
SIXY Discretionary | SIXY +0.96% arrow_upward | 2,373.87 | +22.55 arrow_upward | +0.96% arrow_upward | — | 2,351.32 | 2,360.16 | 2,377.66 | 2,360.16 | — | — |
SIXE Energy | SIXE +0.69% arrow_upward | 1,344.80 | +9.27 arrow_upward | +0.69% arrow_upward | — | 1,335.53 | 1,338.20 | 1,345.22 | 1,334.49 | — | — |
US market summary
Wall Street rebounds following sharp technology selloff
Major U.S. stock indexes opened higher as equity markets staged a recovery from a steep, technology-led downturn. The prior session saw significant losses across the S&P 500, Nasdaq, and Dow Jones Industrial Average due to fading momentum in artificial intelligence and semiconductor stocks.
search_spark
Dive deeper with AI
Treasury yields plunge as government scales up debt buybacks
Long-dated U.S. Treasury yields retreated sharply from near 19-year highs after the Treasury Department announced it would double the size of its liquidity support buyback operations. The repurchases will target the 10-year to 30-year sectors of the market, effectively easing recent borrowing cost anxieties.
search_spark
Dive deeper with AI
Moderna shares skyrocket on positive cancer vaccine trial results
Shares of Moderna nearly doubled in value following highly successful late-stage clinical trial results for its experimental mRNA-based melanoma vaccine, which was tested in combination with Merck's Keytruda. The announcement also lifted Merck's stock alongside other prominent biotech peers.
search_spark
Dive deeper with AI
Oil prices expand gains amid ongoing Middle East tensions
Crude oil futures extended their upward trajectory, touching multi-week highs as diplomatic stagnation continues regarding regional geopolitical friction. The ongoing disputes have specifically stoked investor concerns over potential shipping disruptions surrounding the critical Strait of Hormuz.
search_spark
Dive deeper with AI
Latest updates
Live
·2 min. ago
·3 min. ago
·5 min. ago
·9 min. ago
Show morekeyboard_arrow_down
Upcoming earnings
More upcoming earnings chevron_rightMore news stories
From web sources and news partners
News Corp
·
2 minutes ago
Micron Stock Is Falling Again but the Market Is Missing the Good News
News Corp
·
3 minutes ago
Pressure on bonds abates as Treasury announces buybacks. What may come next.
News Corp
·
5 minutes ago
Moderna’s Cancer Breakthrough Sends the Stock Soaring 84%
Benzinga
·
9 minutes ago
Dow Gains Over 100 Points; Target Posts Upbeat Q2 Earnings
AI content may include mistakes. Learn more